The G6PD Akrokorinthos mutation was found in non-hospitalized patients with neonatal jaundice (NNJ), which is one of the clinical manifestations of G6PD deficiency, and 37% of G6PD residual activity was detected. Here, G6PD is linked to neonatal jaundice.